Previously submitted to: JMIR Dermatology (no longer under consideration since Oct 22, 2025)
Date Submitted: Mar 28, 2024
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Exploring a New Immunotherapy Treatment for Recalcitrant Verrucae
ABSTRACT
Verrucae pose a common challenge for patients of all ages and are difficult to treat. Existing treatment methods such as liquid nitrogen spray, cantharidin application, and physical scraping cause discomfort to the patient and yield limited success. However, recent advancements in immunotherapies present a promising avenue for treating these difficult-to-treat hyperplastic lesions. Local injections of immunotherapies, such as MMR, BCG, Candida Antigen, and Tuberculosis PPD, provide a higher cure rate of recalcitrant verruca while also being less painful.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.